Fecal Calprotectin in Patients Infected with Intestinal Protozoan Infections

Fecal Calprotectin in Patients Infected with Intestinal Protozoan Infections

Calprotectin extracted from stool can be detected easily using ELISA. Numerous studies have shown that fecal calprotectin concentrations demonstrate a good correlation with intestinal inflammation This study aims to detect the relationship between fecal calprotectin and Blastocystis hominis and Entamoeba histolytica infections.

Inclusion Criteria:

120 fecal samples will be collected as the following:

• 40 samples from patients complaining of gastrointestinal manifestations and only infected with B.hominis and E.histolytica.
• 40 samples from patients complaining of gastrointestinal manifestations without any protozoal infection.
• 40 healthy control cross-matched volunteers (without gastrointestinal manifestations, or intestinal parasites).

Exclusion Criteria:

• persons received antiparasitic drugs or antibiotic 2 weeks before sample collection Patients with mixed intestinal protozoa Patients with intestinal protozoa rather than Entamoeba histolytica and Blastocystis